SAGE Therapeutics (SAGE) Reports Q1 Net Loss of $122.1M

SAGE Therapeutics (NASDAQ: SAGE) reported Q1 net loss of $122.1 million. Revenue for the quarter came in at $1.6 million versus the consensus estimate of $3.21 million.

For earnings history and earnings-related data on SAGE Therapeutics (SAGE) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Restoration Hardware (RH) PT Raised to $130 at Stifel After Q1 Earnings
• H.C. Wainwright Reiterates Buy Rating on Anixa Biosciences (ANIX)